Novartis Partners with Generate in $1B Biotech Deal
Novartis and Generate forge $1B+ deal to innovate protein therapeutics using generative AI technology.
- Latest
- Trending
Novartis and Generate forge $1B+ deal to innovate protein therapeutics using generative AI technology.
Discover how AI Centers of Excellence enhance scalability, security, and innovation at Johnson & Johnson.
Explore today's market signals combining real estate and crypto insights, providing actionable investment strategies.
OpenAI CTO Mira Murati leaves company, joins a string of recent executive departures amid significant organizational changes.
EOS Network's Spring 1.0 introduces Savanna, enhancing speed, security and scalability for new blockchain innovations.
Exploring innovative startups in death planning, from eco-friendly burials to digital estate services.
Charles Clough shares why today's market differs from the dot-com era and the potential for inflation and interest rates to ...
Explore Meta's AI, AR, and VR innovations at Connect, including Llama 3.1 and affordable Quest 3S headset.
Discover how AI agents are reshaping blockchain with autonomy and innovation, and the challenges they face.
Ahammune Biosciences raises $5M led by pi Ventures for Phase II trials, expanding R&D for skin disease treatments.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.